Journal
DEVELOPMENTAL CELL
Volume 12, Issue 1, Pages 113-127Publisher
CELL PRESS
DOI: 10.1016/j.devcel.2006.11.003
Keywords
-
Categories
Funding
- EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065789, P01DK056246] Funding Source: NIH RePORTER
- NICHD NIH HHS [P01 HD070394] Funding Source: Medline
- NIDDK NIH HHS [R01 DK065789, P01 DK056246] Funding Source: Medline
Ask authors/readers for more resources
Wnt signaling regulates a variety of developmental processes in animals. Although the beta-catenin-dependent (canonical) pathway is known to control cell fate, a similar role for noncanonical Wnt signaling has not been established in mammals. Moreover, the intracellular cascades for noncanonical Wnt signaling remain to be elucidated. Here, we delineate a pathway in which Wnt3a signals through the G alpha(q/11) subunits of G proteins to activate phosphatidylinositol signaling and PKC delta in the murine ST2 cells. G alpha(q/11)-PKC delta signaling is required for Wnt3a-induced osteoblastogenesis in these cells, and PKC delta homozygous mutant mice exhibit a deficit in embryonic bone formation. Furthermore, Wnt7b, expressed by osteogenic cells in vivo, induces osteoblast differentiation in vitro via the PKC delta-mediated pathway; ablation of Wnt7b in skeletal progenitors results in less bone in the mouse embryo. Together, these results reveal a Wnt-dependent osteogenic mechanism, and they provide a potential target pathway for designing therapeutics to promote bone formation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available